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The autoimmune association of Hashimoto thyroiditis and atrophic body gastritis 
(ABG) is known as thyrogastric syndrome which occurs in at least 14% of 
autoimmune thyroid disease (ATD). ABG is characterized by the loss of HCl and 
intrinsic factor (IF) production and is often underdiagnosed. It is important to 
make an early diagnosis because patients with ABG have greater risk for 
developing gastric cancer and ABG is responsible for anemia. Holotranscobalamin 
(HoloTC) is the biologically active form of vitamin B12 (cobalamin) and represents 
only around 20% of total vitamin B12. HoloTC is believed to be an earlier detection 
marker than total vitamin B12 to diagnose cobalamin deficiency which is especially 
frequent when gastritis manifestations are present. 
 
In this study, we want to compare two markers to determine the vitamin B12 










A total of 118 patients have been separated in 3 groups: “controls” (n=35), 
“autoimmune thyroiditis” (n=60) and “thyrogastric syndrome” (n=23). Major 
criteria for thyrogastric syndrome were evidence of ATD as well as cobalamin 
deficiency and/or ABG in gastroscopy/biopsy and/or hypergastrinemia and/or 
parietal cell autoantibodies (PCA)/intrinsic factor antibodies (IFA) (neither taking 
gastric acid antisecretory drugs nor Metformin). We excluded patients with 
H.Pylori infection as well as patients with estimated glomerular filtration rate 
(eGFR) calculated using MDRD equation <30ml/min/1.73m2 because 
holotranscobalamin concentrations may be affected by renal function. Most 
patients underwent HoloTC, total vitamin B12, TSH, FT4, FT3, ATPO, ATG, TBII, PCA, 
IFA and gastrin determinations to determine their auto-immune status. All 
patients supplemented with vitamin B12 (per os or IM) were excluded of the 
study. 
 
Serum total vitamin B12 was measured using the Cobas 6000 vitamin B12 kit while 




We determined the correlation between holotranscobalamin and total vitamin 
B12. HoloTC was significantly but not strongly associated with total vitamin B12  



































Total Vitamin B12 (pmol/L) 
Correlation Total Vitamin B12/Holotrancobalamin  
(r = 0,5414; p<0,0001) 
Reference range 
Total Vitamin B12 :  147,6-1476 pmol/L 
Holotrancobalamin :  25,1 to 165 pmol/L 
However, more patients were deficient using holotranscoalamin (73,9%) than with total 

























< reference range  into the reference range 
Among the 23 patients affected by thyrogastric syndrome, holotranscobalamin was low 
in 17 patients (73,9%) even though total vitamin B12 was low in 11 patients (47.8%).  
Although three quarter of the group had low holotranscobalamin, some of these had 
normal total vitamin B12 concentrations. Conversely, all patients whose total vitamin 
B12 concentration was low had also  low holotranscobalamin. 
 
The current consensus for holotranscobalamin seems to be that a reference interval of 
40-200 pmol/L is appropriate. In these conditions, 19 patients (82,6%) were low in 
holotranscobalamin. 
 
This suggests that serum holotranscobalamin is a more sensitive marker than total 
vitamin B12 to diagnose vitamin B12 deficiency. This also suggests that patients with 
low holotranscobalamin but with normal total vitamin B12 might have an early stage of 
vitamin B12 deficiency. A total of 6 patients (26%) affected by thyrogastric syndrome 
were <40 years old. 
Conclusion 
 
Holotranscobalamin is as suitable as total vitamin B12 for diagnosis of cobalamin 
deficiency and tends to be lower than total vitamin B12 in thyrogastric patient. As a 
result, these patients would be more quickly supplemented if their vitamin B12 status 
is determined by HoloTC. Using holotranscobalamin as a diagnostic marker would allow 
early therapy before neurological irreversible damage occurs. The initial symptoms of 
cobalamin deficiency are insidious and could easily be overlooked, especially as the 
serum concentration of total vitamin B12 can lie within the reference range. 
Thyrogastric syndrome can be present even in young patients (<40 years). 
The vitamin B12 concentration (both total and holotranscobalamin) was significantly 
lower in “thyrogastric syndrome” group (p < 0,0001) that confirms there is vitamin B12 
malabsorption during gastritis. 
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